Walter M. Lovenberg PhD

Walter M. Lovenberg PhD discloses dealings in 2 companies, chiefly OSI Pharmaceuticals Inc and Merrimack Pharmaceuticals Inc. Between 10 March 2006 and 25 April 2012, the trades on record add up to 23 filings.

On the open market, the record shows 1 purchase worth €7,558 and 13 sales worth €594k. Taken together, the sales exceed the purchases by €586k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants and 6 option exercises. Since January 2012: 1 purchase and no sales on the market.

On 1 May 2012 came the latest disclosure, an option exercise for €9,040 in Merrimack Pharmaceuticals Inc. The latest purchase dates back some time: it was published 5,331 days ago, on 5 April 2012. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.